X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-10-31 | SCLX | Ji Henry | Exec Chairperson | P - Purchase | $0.94 | +8,888 | 680,884 | +1% | +$8,351 | ||||||
2024-10-29 | SCLX | Shah Jaisim | See Remarks | P - Purchase | $0.99 | +32,000 | 265,215 | +14% | +$31,670 | ||||||
2024-10-18 | SCLX | Followwill Dorman | Dir | P - Purchase | $0.99 | +1,000 | 2,300 | +77% | +$990 | ||||||
2024-10-18 | SCLX | Chun Jay | Dir | P - Purchase | $0.95 | +5,000 | 112,511 | +5% | +$4,750 | ||||||
2024-10-17 | SCLX | Wu Yue Alexander | Dir | P - Purchase | $0.95 | +20,000 | 25,000 | +400% | +$18,992 | ||||||
2024-10-17 | SCLX | Lemus David | Dir | P - Purchase | $0.90 | +2,000 | 2,000 | New | +$1,800 | ||||||
2024-10-17 | SCLX | Ji Henry | Exec Chairperson | P - Purchase | $0.97 | +10,000 | 671,996 | +2% | +$9,710 | ||||||
2024-10-16 | SCLX | Shah Jaisim | See Remarks | P - Purchase | $0.99 | +30,000 | 233,215 | +15% | +$29,751 | ||||||
2024-10-16 | SCLX | Ma Stephen Hoi | CFO | P - Purchase | $0.97 | +6,700 | 22,840 | +42% | +$6,499 | ||||||
2024-05-17 | SCLX | Ji Henry | Exec Chairperson | P - Purchase | $0.88 | +50,000 | 655,996 | +8% | +$43,985 | ||||||
2024-05-17 | SCLX | Chun Jay | Dir | P - Purchase | $0.90 | +57,500 | 102,511 | +128% | +$51,641 | ||||||
M | 2024-05-16 | SCLX | Shah Jaisim | See Remarks | P - Purchase | $0.87 | +140,000 | 155,882 | +882% | +$121,945 | |||||
2024-05-17 | SCLX | Ma Stephen Hoi | CFO | P - Purchase | $0.88 | +14,140 | 14,140 | New | +$12,443 | ||||||
D | 2023-09-21 | SCLX | Sorrento Therapeutics, Inc. | 10% | S - Sale+OE | $0.00 | -60,068,585 | 1,917,210 | -97% | -$0 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |